Simo R., Franch-Nadal J., Vlacho B., Real J., Amado E., Flores J., Mata-Cases M., Ortega E., Rigla M., Valles J.-A., Hernandez C., Mauricio D.. Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-world Population-Based Study in Subjects With Type 2 Diabetes. DIABETES CARE. 2023; 46(9)DOI:10.2337/dc22-2521. PMID:37428631. IF:14.800(Q1/1D).

Dieberger A.M., Obermayer-Pietsch B., Harreiter J., Desoye G., van Poppel M.N.M., Simmons D., Corcoy R., Perez J.M.A., Kautzky-Willer A., Damm P., Mathiesen E., Jensen D.M., Andersen L.L.T., Dunne F., Lapolla A., Dalfra M.G., Bertolotto A., Jelsma J.G.M., Galjaard S., Wender-Ozegowska E., Zawiejska A., Hill D., Devlieger R., Snoek F.J.. Physical activity and sedentary time across pregnancy and associations with neonatal weight, adiposity and cord blood parameters: a secondary analysis of the DALI study. INTERNATIONAL JOURNAL OF OBESITY. 2023; 47(9)DOI:10.1038/s41366-023-01347-9. PMID:37500924. IF:4.200(Q1/3D).

Padro T., López-Yerena A., Pérez A., Vilahur G., Badimon L.. Dietary ?3 Fatty Acids and Phytosterols in the Modulation of the HDL Lipidome: A Longitudinal Crossover Clinical Study. Nutrients. 2023; 15(16)DOI:10.3390/nu15163637. PMID:37630826. IF:4.800(Q1/2D).

Arrobas Velilla T., Guijarro C., Campuzano Ruiz R., Rodríguez Piñero M., Valderrama Marcos J.F., Pérez Pérez A., Botana López M.A., Morais López A., García Donaire J.A., Obaya J.C., Castilla Guerra L., Pallares Carratalá V., Egocheaga Cabello I., Salgueira Lazo M., Castellanos Rodrigo M.M., Mostaza Prieto J.M., Gómez Doblas J.J., Buño Soto A.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?. REVISTA CLINICA ESPANOLA. 2023; 223(7)DOI:10.1016/j.rce.2022.11.001. PMID:37302464. IF:2.300(Q2/3D).

Vlacho, B, Simarro, FL, Mata-Cases, M, Miravet, S, Escribano-Serrano, J, Asensio, D, Cortes, X, Franch-Nadal, J. Adherence to antidiabetic treatment among patients managed in primary care centres in Spain: the INTENSE study. Primary Care Diabetes. 2022; 16(6)DOI:10.1016/j.pcd.2022.10.004. PMID:36335018. IF:2.900(Q2/5D).

Puig-Jove, C, Julve, J, Castelblanco, E, Julian, MT, Amigo, N, Andersen, HU, Ahluwalia, TS, Rossing, P, Mauricio, D, Jensen, MT, Alonso, N. The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus. Cardiovascular Diabetology. 2022; 21(1)DOI:10.1186/s12933-022-01652-z. PMID:36434633. IF:9.300(Q1/1D).

Das Pradhan, A, Glynn, RJ, Fruchart, JC, MacFadyen, JG, Zaharris, ES, Everett, BM, Campbell, SE, Oshima, R, Amarenco, P, Blom, DJ, Brinton, EA, Eckel, RH, Elam, MB, Felicio, JS, Ginsberg, HN, Goudev, A, Ishibashi, S, Joseph, J, Kodama, T, Koenig, W, Leiter, LA, Lorenzatti, AJ, Mankovsky, B, Marx, N, Nordestgaard, BG, Pall, D, Ray, KK, Santos, RD, Soran, H, Susekov, A, Tendera, M, Yokote, K, Paynter, NP, Buring, JE, Libby, P, Ridker, PM, PEREZ PEREZ, ANTONIO, Prominent Investigators. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. NEW ENGLAND JOURNAL OF MEDICINE. 2022; 387(21)DOI:10.1056/NEJMoa2210645. PMID:36342113. IF:158.500(Q1/1D).

Castelblanco, E, Granado-Casas, M, Hernandez, M, Pinyol, M, Correig, E, Julve, J, Rojo-Lopez, MI, Alonso, N, Avogaro, A, Ortega, E, Mauricio, D. Diabetic retinopathy predicts cardiovascular disease independently of subclinical atherosclerosis in individuals with type 2 diabetes: A prospective cohort study. Frontiers in Cardiovascular Medicine. 2022; 9DOI:10.3389/fcvm.2022.945421. PMID:36407461. IF:3.600(Q2/5D).